U.S. Court of Appeals for the Federal Circuit, 2020

Valeant Pharmaceuticals v. Mylan Pharmaceuticals

Valeant Pharmaceuticals v. Mylan Pharmaceuticals
U.S. Court of Appeals for the Federal Circuit · Decided November 6, 2020

Valeant Pharmaceuticals v. Mylan Pharmaceuticals

Opinion

Case: 19-2402 Document: 74 Page: 1 Filed: 11/06/2020

United States Court of Appeals for the Federal Circuit ______________________ November 6, 2020 ERRATA ______________________ Appeal No. 2019-2402 VALEANT PHARMACEUTICALS NORTH AMERICA LLC, VALEANT PHARMACEUTICALS IRELAND LTD., DOW PHARMACEUTICAL SCIENCES, INC., KAKEN PHARMACEUTICAL CO., LTD., Plaintiffs-Appellants v. MYLAN PHARMACEUTICALS INC., MYLAN LABORATORIES LTD., MYLAN INC., Defendants-Appellees Decided: November 5, 2020 Precedential Opinion ______________________ Please make the following change: On page 6, line 10, change “Mylan” to —Valeant—.

Case-law data current through December 31, 2025. Source: CourtListener bulk data.